光学イメージング市場:製品(カメラ、レンズ)、技術(OCT、HIS、NIR、PAT)、治療領域(眼科、皮膚科、腫瘍)、用途(病理、術中)、エンドユーザー(病院、研究所)別 - 2027年までの世界予測Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) - Global Forecast to 2027 世界の光学イメージング市場は、2022年の15億米ドルから2027年には29億米ドルに達し、年平均成長率は13.5%と予測されます。競争環境には、2019年1月から2023年1月にかけて主要プレイヤーが採用した主要な成長戦... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー世界の光学イメージング市場は、2022年の15億米ドルから2027年には29億米ドルに達し、年平均成長率は13.5%と予測されます。競争環境には、2019年1月から2023年1月にかけて主要プレイヤーが採用した主要な成長戦略の分析が含まれています。世界の光学イメージング市場のプレイヤーは、世界的なフットプリントを拡大し、協定、売却、拡張、買収など、市場シェアを拡大するためにさまざまな戦略を採用しています。"光学イメージング製品市場において、ソフトウェアが最速の成長セグメントを占める" イメージングプロセスで収集された体積データの効率的な可視化と定量的な評価により、この市場において不可欠なサブセグメントとなっています。既存システムの継続的なアップグレードは、性能向上と正確な意思決定を可能にするハイテクソフトウェアソリューションにより可能です。また、大手企業は、エンドユーザーに設置されている既存のシステムに強化された機能を提供し、コスト効率を確保するために、個別のソフトウェアソリューションを販売しています。このように、本市場において最も急速に成長している分野です。 "光学イメージングアプリケーション市場において、術中が最速の成長セグメントを占める" 医療プロセスにおける再現性と正確さへのニーズの高まりと人件費の高騰が、術中市場の成長を後押ししています。さらに、さまざまな政府機関が投資や資金提供を通じて支援を拡大し、この市場の研究関連活動を促進しています。手術中のワークフローをサポートし、手術の意思決定を容易にすることが、術中分野における光学イメージング・システムの採用が進んだ主な理由です。 "光イメージング市場において、光コヒーレンストモグラフィー部門が最大のシェアを占める" 歯科、婦人科、泌尿器科など多くの分野で使用され、需要が高まっているため、技術分野で最大のシェアを占めています。また、各社が新しいOCTシステムの開発に積極的に取り組んでいることも、市場成長に影響を与えています。光コヒーレンストモグラフィや光音響の技術力を応用した光音響システムなど、技術的に優れたシステムの導入に対するエンドユーザーのニーズの高まりや、より安全で正確なシステムに対する需要の高まりが、市場の成長を促進しています。 "予測期間中、北米が光学イメージング市場を支配する" 予測期間において、北米の光学イメージング市場が支配的であった。世界市場における北米の最大シェアは、がん患者の増加や神経学的イメージングのための先進的な技術を開発するための研究の増加に起因している。主要な光イメージングプレーヤーの存在と老人人口の増加が、市場成長に影響を与える要因となっています。また、北米の米国地域には、前臨床試験や治療薬の開発に従事する多くのバイオ製薬会社や研究所が存在し、地域全体の市場を押し上げています。 主要な市場プレイヤー 光学イメージング市場の主要プレイヤーは、Carl Zeiss Meditec AG(ドイツ)、Abbott(米国)、株式会社トプコン(日本)、キヤノン株式会社(日本)、PerkinElmer, Inc(米国)、Koninklijke Philips N.V. (オランダ)、ハイデルベルクエンジニアリング(米国)、Leica Microsystems(ドイツ)、Headwall Photonics, Inc(米国)、Visionix(米国)、Optical Imaging Ltd. (米国)。(イスラエル)、Optos(スコットランド)、Wasatch Photonics(ユタ州)、ArcScan Inc(米国)、DermaLumics(スペイン)、Cylite Pty Ltd.(オーストラリア)、MOPTIM(広東省)、Michelson Diagnostics Ltd.(英国)、Thorlabs(米国)、浜松ホトニクス株式会社(日本)、iTheraMedical(ドイツ)、Kibero(ドイツ)、Seno Medical(米国)、Aspectus Imaging(ドイツ)、Agfa-Gevaert N.V (ベルギー)です。 本レポートで参照した光学イメージング市場の主要参入企業の内訳(供給サイド別)は以下の通りです: - 企業タイプ別:ティア1-42%、ティア2-31%、ティア3-27%。 - 職位別:Cレベル-30%、ディレクターレベル-45%、その他-25%。 - 地域別北米-42%、欧州-28%、アジア太平洋-19%、RoW-11%。 調査対象範囲 この調査レポートは、様々なセグメントにわたる光学イメージング市場を対象としています。製品別、用途別、エンドユーザー別、技術別、治療分野別、地域別など、さまざまなセグメントにわたるこの市場の市場規模および成長可能性を推定することを目的としています。また、本調査では、市場の主要企業の詳細な競合分析を行い、企業プロフィール、製品および事業の提供に関する主な見解、最近の開発状況、主要な市場戦略も併せて掲載しています。 レポートを購入する主な利点 本レポートは、本市場の市場リーダー/新規参入者に役立ち、光学イメージング市場とそのセグメントの最も近い近似値に関する情報を提供します。本レポートは、関係者が競争環境を理解し、ビジネスをより良く位置づけるための洞察を得て、適切な市場参入戦略を計画するのに役立ちます。また、市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を得る上で、関係者の助けとなることでしょう。 目次1 INTRODUCTION 331.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION & SCOPE 34 1.2.1 INCLUSIONS & EXCLUSIONS 34 1.3 MARKETS COVERED 35 FIGURE 1 OPTICAL IMAGING MARKET SEGMENTATION 35 1.3.1 YEARS CONSIDERED 36 1.4 CURRENCY 36 1.5 STAKEHOLDERS 36 1.6 LIMITATIONS 37 1.7 SUMMARY OF CHANGES 37 1.8 IMPACT OF RECESSION 37 2 RESEARCH METHODOLOGY 38 2.1 RESEARCH APPROACH 38 FIGURE 2 RESEARCH DESIGN 38 2.1.1 SECONDARY DATA 39 2.1.1.1 Key data from secondary sources 40 2.1.2 PRIMARY DATA 40 FIGURE 3 PRIMARY SOURCES 40 2.1.2.1 Key data from primary sources 41 2.1.2.2 Key industry insights 42 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 42 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 43 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 43 2.2 MARKET SIZE ESTIMATION 44 FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION 45 FIGURE 9 COUNTRY-LEVEL ANALYSIS OF OPTICAL IMAGING MARKET 45 FIGURE 10 APPROACH 4: TOP-DOWN APPROACH 46 FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF OPTICAL IMAGING MARKET 48 FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 49 FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 49 2.4 MARKET SHARE ASSUMPTIONS 50 2.5 ASSUMPTIONS 50 3 EXECUTIVE SUMMARY 51 FIGURE 14 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 51 FIGURE 15 OPTICAL IMAGING MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 52 FIGURE 16 OPTICAL IMAGING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 52 FIGURE 17 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION) 53 FIGURE 18 OPTICAL IMAGING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 53 FIGURE 19 GEOGRAPHICAL SNAPSHOT OF OPTICAL IMAGING MARKET 54 4 PREMIUM INSIGHTS 55 4.1 OPTICAL IMAGING MARKET OVERVIEW 55 FIGURE 20 INCREASING PREVALENCE OF EYE DISORDERS TO DRIVE GROWTH IN OPTICAL IMAGING MARKET 55 4.2 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION AND COUNTRY 56 FIGURE 21 PATHOLOGICAL IMAGING SYSTEMS DOMINATED MARKET IN 2021 56 4.3 REGIONAL MIX: OPTICAL IMAGING MARKET 56 FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 56 4.4 OPTICAL IMAGING MARKET: REGIONAL SNAPSHOT 57 FIGURE 23 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 57 5 MARKET OVERVIEW 58 5.1 INTRODUCTION 58 5.2 MARKET DYNAMICS 58 FIGURE 24 OPTICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58 5.2.1 DRIVERS 59 5.2.1.1 Growing geriatric population and subsequent increase in prevalence of eye disorders 59 FIGURE 25 PERCENTAGE OF GERIATRIC POPULATION, BY REGION 59 TABLE 1 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION) 60 5.2.1.2 Technological innovations 60 5.2.1.3 Growing application areas of optical imaging techniques 61 5.2.1.4 Growing need to minimize use of radiation technologies 61 TABLE 2 KEY MARKET DRIVERS 62 5.2.2 RESTRAINTS 62 5.2.2.1 Reimbursement challenges 62 5.2.2.2 Lack of skilled operators 62 TABLE 3 KEY MARKET RESTRAINTS 63 5.2.3 OPPORTUNITIES 63 5.2.3.1 Expansion and market penetration opportunities in emerging economies 63 TABLE 4 GERIATRIC POPULATION TREND IN DEVELOPING REGIONS, 2020 AND 2060 64 5.2.3.2 Growing applications in pharmaceutical & biotechnology research 64 TABLE 5 KEY MARKET OPPORTUNITIES 65 5.2.4 CHALLENGES 65 5.2.4.1 Sustainability of small and medium-sized players 65 5.2.4.2 High cost of optical imaging procedures and extensive data requirements 65 TABLE 6 KEY MARKET CHALLENGES 66 5.3 PORTER’S FIVE FORCES ANALYSIS 66 FIGURE 26 PORTER’S FIVE FORCES ANALYSIS 66 TABLE 7 OPTICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 67 5.3.1 THREAT FROM NEW ENTRANTS 67 5.3.2 THREAT FROM SUBSTITUTES 68 5.3.3 BARGAINING POWER OF SUPPLIERS 68 5.3.4 BARGAINING POWER OF BUYERS 68 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 68 5.4 VALUE CHAIN ANALYSIS 69 FIGURE 27 OPTICAL IMAGING MARKET: VALUE CHAIN ANALYSIS 69 5.5 SUPPLY CHAIN ANALYSIS 69 FIGURE 28 OPTICAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS 71 5.6 REGULATORY ANALYSIS 71 TABLE 8 STRINGENCY OF REGULATIONS FOR OPTICAL IMAGING PRODUCTS, BY REGION 71 5.6.1 NORTH AMERICA 71 5.6.1.1 US 71 TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION 72 5.6.1.2 Canada 72 TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 72 5.6.2 EUROPE 73 5.6.3 ASIA PACIFIC 73 5.6.3.1 Japan 73 TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 74 5.6.3.2 China 74 TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 74 5.6.3.3 India 75 5.7 PATENT ANALYSIS 75 5.8 PRICING ANALYSIS 75 5.9 TRADE DATA 76 5.9.1 US 76 TABLE 13 TOP SUPPLIERS AND BUYERS OF OPTICAL IMAGING SYSTEMS IN US, 2020 76 5.9.2 CHINA 76 5.9.3 UK 77 5.9.4 INDIA 77 6 OPTICAL IMAGING MARKET, BY PRODUCT 78 6.1 INTRODUCTION 79 TABLE 14 GLOBAL OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 79 6.2 IMAGING SYSTEMS 79 TABLE 15 IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80 TABLE 16 IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80 6.2.1 OPTICAL IMAGING SYSTEMS 81 6.2.1.1 Growing need for high-resolution imaging in ophthalmology to drive market growth 81 TABLE 17 KEY OPTICAL IMAGING SYSTEMS 82 TABLE 18 OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83 6.2.2 SPECTRAL IMAGING SYSTEMS 83 6.2.2.1 Growing need for advanced imaging techniques to promote growth 83 TABLE 19 SPECTRAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84 6.3 CAMERAS 84 6.3.1 BENEFITS SUCH AS BETTER SENSITIVITY AND HIGH-RESOLUTION IMAGING CAPABILITIES TO DRIVE DEMAND FOR CAMERAS 84 TABLE 20 OPTICAL IMAGING CAMERAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85 6.4 SOFTWARE 85 6.4.1 GROWING DEMAND FOR ADVANCED AND OPTIMIZED OPTICAL IMAGING SOFTWARE TO SUPPORT GROWTH 85 TABLE 21 OPTICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86 6.5 LENSES 86 6.5.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGING TO BOOST DEMAND FOR LENSES 86 TABLE 22 OPTICAL IMAGING LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87 6.6 ILLUMINATION SYSTEMS 87 6.6.1 GROWING DEMAND FOR NON-IONIZING AND RADIATION-FREE TECHNIQUES TO BOOST MARKET GROWTH 87 TABLE 23 OPTICAL IMAGING ILLUMINATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88 6.7 OTHER PRODUCTS 88 TABLE 24 OTHER OPTICAL IMAGING PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89 7 OPTICAL IMAGING MARKET, BY TECHNIQUE 90 7.1 INTRODUCTION 91 TABLE 25 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 91 7.2 OPTICAL COHERENCE TOMOGRAPHY (OCT) 91 7.2.1 RISING INNOVATIONS IN OCT TO DRIVE MARKET GROWTH 91 TABLE 26 OPTICAL COHERENCE TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92 7.3 NEAR-INFRARED SPECTROSCOPY (NIRS) 93 7.3.1 INCREASING FUNDS BY GOVERNMENT ORGANIZATIONS AND UNIVERSITIES FOR R&D TO PROMOTE MARKET GROWTH 93 TABLE 27 NEAR-INFRARED SPECTROSCOPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94 7.4 HYPERSPECTRAL IMAGING (HSI) 94 7.4.1 GROWING INDUSTRIAL APPLICATIONS OF HYPERSPECTRAL IMAGING TO BOOST GROWTH 94 TABLE 28 HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95 7.5 PHOTOACOUSTIC TOMOGRAPHY (PAT) 95 7.5.1 RISING CANCER CASES AND BROAD APPLICATIONS IN RESEARCH AND CLINICAL CARE TO SUPPORT GROWTH 95 TABLE 29 PHOTOACOUSTIC TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96 8 OPTICAL IMAGING MARKET, BY APPLICATION 97 8.1 INTRODUCTION 98 TABLE 30 OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98 8.2 PATHOLOGICAL IMAGING 98 8.2.1 LOW OPERATIONAL COSTS AND RELATIVE EASE OF USE TO DRIVE GROWTH 98 TABLE 31 PATHOLOGICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99 8.3 INTRA-OPERATIVE IMAGING 99 8.3.1 RISING LABOR COSTS AND INCREASING NEED FOR ACCURACY IN MEDICAL PROCESSES TO DRIVE MARKET 99 TABLE 32 INTRA-OPERATIVE IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100 9 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA 101 9.1 INTRODUCTION 102 TABLE 33 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 102 9.2 OPHTHALMOLOGY 102 9.2.1 GROWING NUMBER OF OPHTHALMIC PROCEDURES TO PROPEL MARKET 102 TABLE 34 OPTICAL IMAGING MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 103 9.3 ONCOLOGY 104 9.3.1 GROWING PRECLINICAL DRUG DEVELOPMENT RESEARCH ON CANCER TO PROMOTE GROWTH 104 TABLE 35 OPTICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 105 9.4 CARDIOLOGY 105 9.4.1 ADVANCED INNOVATIONS IN OCT TECHNIQUES FOR CARDIOLOGY APPLICATIONS TO BOOST MARKET 105 TABLE 36 OPTICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 106 9.5 DERMATOLOGY 106 9.5.1 GROWING INCIDENCE OF SKIN CANCER TO FUEL DEMAND FOR OPTICAL IMAGING 106 TABLE 37 OPTICAL IMAGING MARKET FOR DERMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 107 9.6 NEUROLOGY 107 9.6.1 LOW COST AND GROWING UTILIZATION OF OPTICAL IMAGING TECHNIQUES TO PROMOTE GROWTH 107 TABLE 38 OPTICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 108 9.7 OTHER THERAPEUTIC AREAS 109 TABLE 39 OPTICAL IMAGING MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2020–2027 (USD MILLION) 109 10 OPTICAL IMAGING MARKET, BY END USER 110 10.1 INTRODUCTION 111 TABLE 40 OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 111 10.2 HOSPITALS & CLINICS 111 10.2.1 INCREASING CLINICAL APPLICATIONS OF OPTICAL IMAGING TECHNIQUES IN HOSPITALS TO DRIVE MARKET 111 TABLE 41 OPTICAL IMAGING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 112 10.3 RESEARCH LABORATORIES 113 10.3.1 AVAILABILITY OF RESEARCH FUNDING FROM PRIVATE AND GOVERNMENT ORGANIZATIONS TO PROMOTE GROWTH 113 TABLE 42 OPTICAL IMAGING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 114 10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 114 10.4.1 GREATER UTILIZATION OF OPTICAL IMAGING TECHNIQUES IN DRUG DISCOVERY PROCESSES TO SUPPORT MARKET 114 TABLE 43 OPTICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 116 11 OPTICAL IMAGING MARKET, BY REGION 117 11.1 INTRODUCTION 118 FIGURE 29 OPTICAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 118 TABLE 44 OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119 11.2 NORTH AMERICA 119 11.2.1 NORTH AMERICA: RECESSION IMPACT 120 FIGURE 30 NORTH AMERICA: OPTICAL IMAGING MARKET SNAPSHOT 120 TABLE 45 NORTH AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121 TABLE 46 NORTH AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121 TABLE 47 NORTH AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121 TABLE 48 NORTH AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122 TABLE 49 NORTH AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 122 TABLE 50 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122 TABLE 51 NORTH AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 123 11.2.2 US 123 11.2.2.1 Presence of several large hospitals & health systems to increase number of imaging & diagnostic procedures in country 123 TABLE 52 US: MACROECONOMIC INDICATORS 124 TABLE 53 US: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 124 TABLE 54 US: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124 TABLE 55 US: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125 TABLE 56 US: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 125 TABLE 57 US: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125 TABLE 58 US: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 126 11.2.3 CANADA 126 11.2.3.1 Availability of research funding to drive growth 126 TABLE 59 CANADA: MACROECONOMIC INDICATORS 126 TABLE 60 CANADA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127 TABLE 61 CANADA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127 TABLE 62 CANADA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 127 TABLE 63 CANADA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 128 TABLE 64 CANADA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128 TABLE 65 CANADA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 128 11.3 EUROPE 129 11.3.1 EUROPE: RECESSION IMPACT 129 FIGURE 31 EUROPE: OPTICAL IMAGING MARKET SNAPSHOT 130 TABLE 66 EUROPE: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131 TABLE 67 EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131 TABLE 68 EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131 TABLE 69 EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132 TABLE 70 EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 132 TABLE 71 EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 132 TABLE 72 EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 133 11.3.2 GERMANY 133 11.3.2.1 Robust healthcare spending to support market in Germany 133 TABLE 73 GERMANY: MACROECONOMIC INDICATORS 134 TABLE 74 GERMANY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134 TABLE 75 GERMANY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134 TABLE 76 GERMANY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 135 TABLE 77 GERMANY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 135 TABLE 78 GERMANY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135 TABLE 79 GERMANY: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 136 11.3.3 FRANCE 136 11.3.3.1 Increasing healthcare expenditure and rising medical tourism in France to propel growth 136 TABLE 80 FRANCE: MACROECONOMIC INDICATORS 137 TABLE 81 FRANCE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 137 TABLE 82 FRANCE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137 TABLE 83 FRANCE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 138 TABLE 84 FRANCE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 138 TABLE 85 FRANCE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 138 TABLE 86 FRANCE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 139 11.3.4 UK 139 11.3.4.1 Growing adoption of optical imaging techniques and in vivo research applications to drive growth 139 TABLE 87 UK: MACROECONOMIC INDICATORS 140 TABLE 88 UK: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 140 TABLE 89 UK: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140 TABLE 90 UK: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 141 TABLE 91 UK: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 141 TABLE 92 UK: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 141 TABLE 93 UK: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 142 11.3.5 ITALY 142 11.3.5.1 Presence of major pharmaceutical & research institutes to drive market 142 TABLE 94 ITALY: MACROECONOMIC INDICATORS 143 TABLE 95 ITALY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 143 TABLE 96 ITALY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143 TABLE 97 ITALY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 144 TABLE 98 ITALY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 144 TABLE 99 ITALY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 144 TABLE 100 ITALY: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 145 11.3.6 SPAIN 145 11.3.6.1 Increasing development in biomedical sciences to drive growth 145 TABLE 101 SPAIN: MACROECONOMIC INDICATORS 146 TABLE 102 SPAIN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 146 TABLE 103 SPAIN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146 TABLE 104 SPAIN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 147 TABLE 105 SPAIN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 147 TABLE 106 SPAIN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147 TABLE 107 SPAIN: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 148 11.3.7 REST OF EUROPE 148 TABLE 108 SHARE OF GERIATRIC POPULATION (AGED 65 YEARS AND ABOVE) IN ROE COUNTRIES 149 TABLE 109 REST OF EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149 TABLE 110 REST OF EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149 TABLE 111 REST OF EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 150 TABLE 112 REST OF EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 150 TABLE 113 REST OF EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150 TABLE 114 REST OF EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 151 11.4 ASIA PACIFIC 151 11.4.1 ASIA PACIFIC: RECESSION IMPACT 152 FIGURE 32 ASIA PACIFIC: OPTICAL IMAGING MARKET SNAPSHOT 152 TABLE 115 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153 TABLE 116 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 153 TABLE 117 ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153 TABLE 118 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 154 TABLE 119 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 154 TABLE 120 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154 TABLE 121 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 155 11.4.2 JAPAN 155 11.4.2.1 Established pharmaceutical & biotechnology research base to propel market 155 TABLE 122 JAPAN: MACROECONOMIC INDICATORS 156 TABLE 123 JAPAN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 156 TABLE 124 JAPAN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156 TABLE 125 JAPAN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 157 TABLE 126 JAPAN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 157 TABLE 127 JAPAN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 157 TABLE 128 JAPAN: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 158 11.4.3 CHINA 158 11.4.3.1 Presence of large population base and favorable initiatives undertaken by authorities to aid growth 158 TABLE 129 CHINA: MACROECONOMIC INDICATORS 159 TABLE 130 CHINA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 159 TABLE 131 CHINA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159 TABLE 132 CHINA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 160 TABLE 133 CHINA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 160 TABLE 134 CHINA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160 TABLE 135 CHINA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 161 11.4.4 INDIA 161 11.4.4.1 Rising adoption of advanced diagnostic imaging technologies by healthcare providers to boost market 161 TABLE 136 INDIA: MACROECONOMIC INDICATORS 162 TABLE 137 INDIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 162 TABLE 138 INDIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162 TABLE 139 INDIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 163 TABLE 140 INDIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 163 TABLE 141 INDIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 163 TABLE 142 INDIA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 164 11.4.5 AUSTRALIA 164 11.4.5.1 Growing awareness of healthcare services and rising healthcare expenditure to support market 164 TABLE 143 AUSTRALIA: MACROECONOMIC INDICATORS 164 TABLE 144 AUSTRALIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 165 TABLE 145 AUSTRALIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165 TABLE 146 AUSTRALIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 165 TABLE 147 AUSTRALIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 166 TABLE 148 AUSTRALIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 166 TABLE 149 AUSTRALIA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 166 11.4.6 SOUTH KOREA 167 11.4.6.1 Growing expenditure on improved healthcare services and rising geriatric population to propel growth 167 TABLE 150 SOUTH KOREA: MACROECONOMIC INDICATORS 167 TABLE 151 SOUTH KOREA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 167 TABLE 152 SOUTH KOREA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168 TABLE 153 SOUTH KOREA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 168 TABLE 154 SOUTH KOREA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 168 TABLE 155 OUTH KOREA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 169 TABLE 156 SOUTH KOREA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 169 11.4.7 REST OF ASIA PACIFIC 169 TABLE 157 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170 TABLE 158 REST OF ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170 TABLE 159 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 170 TABLE 160 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 171 TABLE 161 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 171 TABLE 162 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 171 11.5 LATIN AMERICA 172 11.5.1 LATIN AMERICA: RECESSION IMPACT 172 TABLE 163 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 172 TABLE 164 LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 173 TABLE 165 LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 173 TABLE 166 LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 173 TABLE 167 LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 174 TABLE 168 LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 174 TABLE 169 LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 174 11.5.2 BRAZIL 175 11.5.2.1 Improved GDP expenditure on healthcare 175 TABLE 170 BRAZIL: MACROECONOMIC INDICATORS 175 TABLE 171 BRAZIL: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175 TABLE 172 BRAZIL: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176 TABLE 173 BRAZIL: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 176 TABLE 174 BRAZIL: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 176 TABLE 175 BRAZIL: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 177 TABLE 176 BRAZIL: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 177 11.5.3 REST OF LATIN AMERICA 177 TABLE 177 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 178 TABLE 178 REST OF LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 178 TABLE 179 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 178 TABLE 180 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 179 TABLE 181 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 179 TABLE 182 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 179 11.6 MIDDLE EAST & AFRICA 180 11.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH 180 11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 180 TABLE 183 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 181 TABLE 184 MIDDLE EAST & AFRICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181 TABLE 185 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 181 TABLE 186 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 182 TABLE 187 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 182 TABLE 188 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 182 12 COMPETITIVE LANDSCAPE 183 12.1 INTRODUCTION 183 FIGURE 33 KEY MARKET DEVELOPMENTS (JANUARY 2020 TO JANUARY 2023) 184 12.2 REVENUE SHARE ANALYSIS 185 FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET 185 12.3 MARKET SHARE ANALYSIS 186 FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET, 2021 186 12.4 COMPANY EVALUATION QUADRANT 187 12.4.1 STARS 188 12.4.2 EMERGING LEADERS 188 12.4.3 PERVASIVE PLAYERS 188 12.4.4 PARTICIPANTS 188 FIGURE 36 OPTICAL IMAGING MARKET: GLOBAL COMPANY EVALUATION QUADRANT 189 12.5 START-UP/SME EVALUATION QUADRANT 190 12.5.1 PROGRESSIVE COMPANIES 190 12.5.2 STARTING BLOCKS 190 12.5.3 RESPONSIVE COMPANIES 190 12.5.4 DYNAMIC COMPANIES 190 FIGURE 37 OPTICAL IMAGING MARKET: GLOBAL START-UP/SME MATRIX 191 12.6 COMPETITIVE BENCHMARKING 192 12.6.1 COMPANY FOOTPRINT FOR KEY PLAYERS 192 12.6.2 PRODUCT FOOTPRINT 193 12.6.3 TECHNIQUE FOOTPRINT 194 12.6.4 THERAPEUTIC AREA FOOTPRINT 195 12.6.5 REGIONAL FOOTPRINT 196 12.7 GEOGRAPHIC FOOTPRINT OF KEY PLAYERS 197 FIGURE 38 GEOGRAPHIC REVENUE MIX: KEY PLAYERS 197 12.8 COMPETITIVE SITUATION AND TRENDS 197 12.8.1 PRODUCT LAUNCHES & APPROVALS 198 TABLE 189 OPTICAL IMAGING MARKET: PRODUCT LAUNCHES (JANUARY 2019 TO JANUARY 2023) 198 12.8.2 DEALS 198 TABLE 190 OPTICAL IMAGING MARKET: DEALS(JANUARY 2019 TO JANUARY 2023) 198 12.8.3 OTHER DEVELOPMENTS 199 TABLE 191 OPTICAL IMAGING MARKET: OTHER DEVELOPMENTS (JANUARY 2019 TO JANUARY 2023) 199 13 COMPANY PROFILES 200 13.1 KEY PLAYERS 200 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 13.1.1 CARL ZEISS MEDITEC AG 200 TABLE 192 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW 200 FIGURE 39 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021) 201 13.1.2 TOPCON CORPORATION 204 TABLE 193 TOPCON CORPORATION: BUSINESS OVERVIEW 204 FIGURE 40 TOPCON CORPORATION: COMPANY SNAPSHOT (2021) 205 13.1.3 CANON INC. 207 TABLE 194 CANON INC.: BUSINESS OVERVIEW 207 FIGURE 41 CANON INC.: COMPANY SNAPSHOT (2021) 208 13.1.4 ABBOTT LABORATORIES INC. 211 TABLE 195 ABBOTT LABORATORIES: BUSINESS OVERVIEW 211 FIGURE 42 ABBOTT LABORATORIES INC.: COMPANY SNAPSHOT (2021) 212 13.1.5 KONINKLIJKE PHILIPS N.V. 215 TABLE 196 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 215 FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021) 216 13.1.6 PERKINELMER, INC. 218 TABLE 197 PERKINELMER, INC.: BUSINESS OVERVIEW 218 FIGURE 44 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 219 13.1.7 LEICA MICROSYSTEMS (DANAHER CORPORATION) 220 TABLE 198 LEICA MICROSYSTEMS (DANAHER CORPORATION): BUSINESS OVERVIEW 220 FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 221 13.1.8 AGFA-GEVAERT N.V. 223 TABLE 199 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW 223 FIGURE 46 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2021) 224 13.1.9 HAMAMATSU PHOTONICS K.K. 225 TABLE 200 HAMAMATSU PHOTONICS K.K.: BUSINESS OVERVIEW 225 FIGURE 47 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2021) 225 13.2 OTHER PLAYERS 227 13.2.1 HEIDELBERG ENGINEERING, INC. 227 TABLE 201 HEIDELBERG ENGINEERING, INC.: BUSINESS OVERVIEW 227 13.2.2 HEADWALL PHOTONICS, INC. 229 TABLE 202 HEADWALL PHOTONICS, INC.: BUSINESS OVERVIEW 229 13.2.3 VISIONIX (FORMERLY LUNEAU TECHNOLOGY USA & OPTOVUE INC.) 231 TABLE 203 VISIONIX: BUSINESS OVERVIEW 231 13.2.4 OPTICAL IMAGING LTD. 233 TABLE 204 OPTICAL IMAGING LTD.: BUSINESS OVERVIEW 233 13.2.5 OPTOS 234 TABLE 205 OPTOS: BUSINESS OVERVIEW 234 13.2.6 WASATCH PHOTONICS 235 TABLE 206 WASATCH PHOTONICS: BUSINESS OVERVIEW 235 13.2.7 ARCSCAN INC. 236 TABLE 207 ARCSCAN INC.: BUSINESS OVERVIEW 236 13.2.8 DERMALUMICS 237 TABLE 208 DERMALUMICS: BUSINESS OVERVIEW 237 13.2.9 CYLITE PTY LTD. 238 TABLE 209 CYLITE PTY LTD.: BUSINESS OVERVIEW 238 13.2.10 MOPTIM 239 TABLE 210 MOPTIM: BUSINESS OVERVIEW 239 13.2.11 MICHELSON DIAGNOSTICS LTD. 240 TABLE 211 MICHELSON DIAGNOSTICS LTD.: BUSINESS OVERVIEW 240 13.2.12 THORLABS 241 TABLE 212 THORLABS: BUSINESS OVERVIEW 241 13.2.13 ITHERAMEDICAL 242 TABLE 213 ITHERAMEDICAL: BUSINESS OVERVIEW 242 13.2.14 KIBERO 244 TABLE 214 KIBERO: BUSINESS OVERVIEW 244 13.2.15 SENO MEDICAL 246 TABLE 215 SENO MEDICAL: BUSINESS OVERVIEW 246 13.2.16 ASPECTUS IMAGING 248 TABLE 216 ASPECTUS IMAGING: BUSINESS OVERVIEW 248 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 14 APPENDIX 249 14.1 INSIGHTS FROM INDUSTRY EXPERTS 249 14.2 DISCUSSION GUIDE 250 14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 255 14.4 CUSTOMIZATION OPTIONS 257 14.5 RELATED REPORTS 257 14.6 AUTHOR DETAILS 258
SummaryThe global optical imaging market is projected to reach USD 2.9 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 13.5%. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2019 and January 2023. Players in the global optical imaging market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions. Table of Contents1 INTRODUCTION 331.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION & SCOPE 34 1.2.1 INCLUSIONS & EXCLUSIONS 34 1.3 MARKETS COVERED 35 FIGURE 1 OPTICAL IMAGING MARKET SEGMENTATION 35 1.3.1 YEARS CONSIDERED 36 1.4 CURRENCY 36 1.5 STAKEHOLDERS 36 1.6 LIMITATIONS 37 1.7 SUMMARY OF CHANGES 37 1.8 IMPACT OF RECESSION 37 2 RESEARCH METHODOLOGY 38 2.1 RESEARCH APPROACH 38 FIGURE 2 RESEARCH DESIGN 38 2.1.1 SECONDARY DATA 39 2.1.1.1 Key data from secondary sources 40 2.1.2 PRIMARY DATA 40 FIGURE 3 PRIMARY SOURCES 40 2.1.2.1 Key data from primary sources 41 2.1.2.2 Key industry insights 42 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 42 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 43 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 43 2.2 MARKET SIZE ESTIMATION 44 FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION 45 FIGURE 9 COUNTRY-LEVEL ANALYSIS OF OPTICAL IMAGING MARKET 45 FIGURE 10 APPROACH 4: TOP-DOWN APPROACH 46 FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF OPTICAL IMAGING MARKET 48 FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 49 FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 49 2.4 MARKET SHARE ASSUMPTIONS 50 2.5 ASSUMPTIONS 50 3 EXECUTIVE SUMMARY 51 FIGURE 14 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 51 FIGURE 15 OPTICAL IMAGING MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 52 FIGURE 16 OPTICAL IMAGING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 52 FIGURE 17 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2022 VS. 2027 (USD MILLION) 53 FIGURE 18 OPTICAL IMAGING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 53 FIGURE 19 GEOGRAPHICAL SNAPSHOT OF OPTICAL IMAGING MARKET 54 4 PREMIUM INSIGHTS 55 4.1 OPTICAL IMAGING MARKET OVERVIEW 55 FIGURE 20 INCREASING PREVALENCE OF EYE DISORDERS TO DRIVE GROWTH IN OPTICAL IMAGING MARKET 55 4.2 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION AND COUNTRY 56 FIGURE 21 PATHOLOGICAL IMAGING SYSTEMS DOMINATED MARKET IN 2021 56 4.3 REGIONAL MIX: OPTICAL IMAGING MARKET 56 FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 56 4.4 OPTICAL IMAGING MARKET: REGIONAL SNAPSHOT 57 FIGURE 23 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 57 5 MARKET OVERVIEW 58 5.1 INTRODUCTION 58 5.2 MARKET DYNAMICS 58 FIGURE 24 OPTICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58 5.2.1 DRIVERS 59 5.2.1.1 Growing geriatric population and subsequent increase in prevalence of eye disorders 59 FIGURE 25 PERCENTAGE OF GERIATRIC POPULATION, BY REGION 59 TABLE 1 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2013 VS. 2020 VS. 2040 (MILLION) 60 5.2.1.2 Technological innovations 60 5.2.1.3 Growing application areas of optical imaging techniques 61 5.2.1.4 Growing need to minimize use of radiation technologies 61 TABLE 2 KEY MARKET DRIVERS 62 5.2.2 RESTRAINTS 62 5.2.2.1 Reimbursement challenges 62 5.2.2.2 Lack of skilled operators 62 TABLE 3 KEY MARKET RESTRAINTS 63 5.2.3 OPPORTUNITIES 63 5.2.3.1 Expansion and market penetration opportunities in emerging economies 63 TABLE 4 GERIATRIC POPULATION TREND IN DEVELOPING REGIONS, 2020 AND 2060 64 5.2.3.2 Growing applications in pharmaceutical & biotechnology research 64 TABLE 5 KEY MARKET OPPORTUNITIES 65 5.2.4 CHALLENGES 65 5.2.4.1 Sustainability of small and medium-sized players 65 5.2.4.2 High cost of optical imaging procedures and extensive data requirements 65 TABLE 6 KEY MARKET CHALLENGES 66 5.3 PORTER’S FIVE FORCES ANALYSIS 66 FIGURE 26 PORTER’S FIVE FORCES ANALYSIS 66 TABLE 7 OPTICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 67 5.3.1 THREAT FROM NEW ENTRANTS 67 5.3.2 THREAT FROM SUBSTITUTES 68 5.3.3 BARGAINING POWER OF SUPPLIERS 68 5.3.4 BARGAINING POWER OF BUYERS 68 5.3.5 INTENSITY OF COMPETITIVE RIVALRY 68 5.4 VALUE CHAIN ANALYSIS 69 FIGURE 27 OPTICAL IMAGING MARKET: VALUE CHAIN ANALYSIS 69 5.5 SUPPLY CHAIN ANALYSIS 69 FIGURE 28 OPTICAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS 71 5.6 REGULATORY ANALYSIS 71 TABLE 8 STRINGENCY OF REGULATIONS FOR OPTICAL IMAGING PRODUCTS, BY REGION 71 5.6.1 NORTH AMERICA 71 5.6.1.1 US 71 TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION 72 5.6.1.2 Canada 72 TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 72 5.6.2 EUROPE 73 5.6.3 ASIA PACIFIC 73 5.6.3.1 Japan 73 TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 74 5.6.3.2 China 74 TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES 74 5.6.3.3 India 75 5.7 PATENT ANALYSIS 75 5.8 PRICING ANALYSIS 75 5.9 TRADE DATA 76 5.9.1 US 76 TABLE 13 TOP SUPPLIERS AND BUYERS OF OPTICAL IMAGING SYSTEMS IN US, 2020 76 5.9.2 CHINA 76 5.9.3 UK 77 5.9.4 INDIA 77 6 OPTICAL IMAGING MARKET, BY PRODUCT 78 6.1 INTRODUCTION 79 TABLE 14 GLOBAL OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 79 6.2 IMAGING SYSTEMS 79 TABLE 15 IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 80 TABLE 16 IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80 6.2.1 OPTICAL IMAGING SYSTEMS 81 6.2.1.1 Growing need for high-resolution imaging in ophthalmology to drive market growth 81 TABLE 17 KEY OPTICAL IMAGING SYSTEMS 82 TABLE 18 OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83 6.2.2 SPECTRAL IMAGING SYSTEMS 83 6.2.2.1 Growing need for advanced imaging techniques to promote growth 83 TABLE 19 SPECTRAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84 6.3 CAMERAS 84 6.3.1 BENEFITS SUCH AS BETTER SENSITIVITY AND HIGH-RESOLUTION IMAGING CAPABILITIES TO DRIVE DEMAND FOR CAMERAS 84 TABLE 20 OPTICAL IMAGING CAMERAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85 6.4 SOFTWARE 85 6.4.1 GROWING DEMAND FOR ADVANCED AND OPTIMIZED OPTICAL IMAGING SOFTWARE TO SUPPORT GROWTH 85 TABLE 21 OPTICAL IMAGING SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86 6.5 LENSES 86 6.5.1 TECHNOLOGICAL ADVANCEMENTS IN IMAGING TO BOOST DEMAND FOR LENSES 86 TABLE 22 OPTICAL IMAGING LENSES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87 6.6 ILLUMINATION SYSTEMS 87 6.6.1 GROWING DEMAND FOR NON-IONIZING AND RADIATION-FREE TECHNIQUES TO BOOST MARKET GROWTH 87 TABLE 23 OPTICAL IMAGING ILLUMINATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88 6.7 OTHER PRODUCTS 88 TABLE 24 OTHER OPTICAL IMAGING PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89 7 OPTICAL IMAGING MARKET, BY TECHNIQUE 90 7.1 INTRODUCTION 91 TABLE 25 OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 91 7.2 OPTICAL COHERENCE TOMOGRAPHY (OCT) 91 7.2.1 RISING INNOVATIONS IN OCT TO DRIVE MARKET GROWTH 91 TABLE 26 OPTICAL COHERENCE TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92 7.3 NEAR-INFRARED SPECTROSCOPY (NIRS) 93 7.3.1 INCREASING FUNDS BY GOVERNMENT ORGANIZATIONS AND UNIVERSITIES FOR R&D TO PROMOTE MARKET GROWTH 93 TABLE 27 NEAR-INFRARED SPECTROSCOPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94 7.4 HYPERSPECTRAL IMAGING (HSI) 94 7.4.1 GROWING INDUSTRIAL APPLICATIONS OF HYPERSPECTRAL IMAGING TO BOOST GROWTH 94 TABLE 28 HYPERSPECTRAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95 7.5 PHOTOACOUSTIC TOMOGRAPHY (PAT) 95 7.5.1 RISING CANCER CASES AND BROAD APPLICATIONS IN RESEARCH AND CLINICAL CARE TO SUPPORT GROWTH 95 TABLE 29 PHOTOACOUSTIC TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96 8 OPTICAL IMAGING MARKET, BY APPLICATION 97 8.1 INTRODUCTION 98 TABLE 30 OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98 8.2 PATHOLOGICAL IMAGING 98 8.2.1 LOW OPERATIONAL COSTS AND RELATIVE EASE OF USE TO DRIVE GROWTH 98 TABLE 31 PATHOLOGICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99 8.3 INTRA-OPERATIVE IMAGING 99 8.3.1 RISING LABOR COSTS AND INCREASING NEED FOR ACCURACY IN MEDICAL PROCESSES TO DRIVE MARKET 99 TABLE 32 INTRA-OPERATIVE IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100 9 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA 101 9.1 INTRODUCTION 102 TABLE 33 OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 102 9.2 OPHTHALMOLOGY 102 9.2.1 GROWING NUMBER OF OPHTHALMIC PROCEDURES TO PROPEL MARKET 102 TABLE 34 OPTICAL IMAGING MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 103 9.3 ONCOLOGY 104 9.3.1 GROWING PRECLINICAL DRUG DEVELOPMENT RESEARCH ON CANCER TO PROMOTE GROWTH 104 TABLE 35 OPTICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 105 9.4 CARDIOLOGY 105 9.4.1 ADVANCED INNOVATIONS IN OCT TECHNIQUES FOR CARDIOLOGY APPLICATIONS TO BOOST MARKET 105 TABLE 36 OPTICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 106 9.5 DERMATOLOGY 106 9.5.1 GROWING INCIDENCE OF SKIN CANCER TO FUEL DEMAND FOR OPTICAL IMAGING 106 TABLE 37 OPTICAL IMAGING MARKET FOR DERMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 107 9.6 NEUROLOGY 107 9.6.1 LOW COST AND GROWING UTILIZATION OF OPTICAL IMAGING TECHNIQUES TO PROMOTE GROWTH 107 TABLE 38 OPTICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 108 9.7 OTHER THERAPEUTIC AREAS 109 TABLE 39 OPTICAL IMAGING MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2020–2027 (USD MILLION) 109 10 OPTICAL IMAGING MARKET, BY END USER 110 10.1 INTRODUCTION 111 TABLE 40 OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 111 10.2 HOSPITALS & CLINICS 111 10.2.1 INCREASING CLINICAL APPLICATIONS OF OPTICAL IMAGING TECHNIQUES IN HOSPITALS TO DRIVE MARKET 111 TABLE 41 OPTICAL IMAGING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 112 10.3 RESEARCH LABORATORIES 113 10.3.1 AVAILABILITY OF RESEARCH FUNDING FROM PRIVATE AND GOVERNMENT ORGANIZATIONS TO PROMOTE GROWTH 113 TABLE 42 OPTICAL IMAGING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 114 10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 114 10.4.1 GREATER UTILIZATION OF OPTICAL IMAGING TECHNIQUES IN DRUG DISCOVERY PROCESSES TO SUPPORT MARKET 114 TABLE 43 OPTICAL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 116 11 OPTICAL IMAGING MARKET, BY REGION 117 11.1 INTRODUCTION 118 FIGURE 29 OPTICAL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 118 TABLE 44 OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119 11.2 NORTH AMERICA 119 11.2.1 NORTH AMERICA: RECESSION IMPACT 120 FIGURE 30 NORTH AMERICA: OPTICAL IMAGING MARKET SNAPSHOT 120 TABLE 45 NORTH AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121 TABLE 46 NORTH AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121 TABLE 47 NORTH AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 121 TABLE 48 NORTH AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122 TABLE 49 NORTH AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 122 TABLE 50 NORTH AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122 TABLE 51 NORTH AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 123 11.2.2 US 123 11.2.2.1 Presence of several large hospitals & health systems to increase number of imaging & diagnostic procedures in country 123 TABLE 52 US: MACROECONOMIC INDICATORS 124 TABLE 53 US: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 124 TABLE 54 US: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124 TABLE 55 US: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125 TABLE 56 US: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 125 TABLE 57 US: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125 TABLE 58 US: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 126 11.2.3 CANADA 126 11.2.3.1 Availability of research funding to drive growth 126 TABLE 59 CANADA: MACROECONOMIC INDICATORS 126 TABLE 60 CANADA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127 TABLE 61 CANADA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127 TABLE 62 CANADA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 127 TABLE 63 CANADA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 128 TABLE 64 CANADA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128 TABLE 65 CANADA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 128 11.3 EUROPE 129 11.3.1 EUROPE: RECESSION IMPACT 129 FIGURE 31 EUROPE: OPTICAL IMAGING MARKET SNAPSHOT 130 TABLE 66 EUROPE: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131 TABLE 67 EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131 TABLE 68 EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131 TABLE 69 EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132 TABLE 70 EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 132 TABLE 71 EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 132 TABLE 72 EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 133 11.3.2 GERMANY 133 11.3.2.1 Robust healthcare spending to support market in Germany 133 TABLE 73 GERMANY: MACROECONOMIC INDICATORS 134 TABLE 74 GERMANY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134 TABLE 75 GERMANY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134 TABLE 76 GERMANY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 135 TABLE 77 GERMANY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 135 TABLE 78 GERMANY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135 TABLE 79 GERMANY: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 136 11.3.3 FRANCE 136 11.3.3.1 Increasing healthcare expenditure and rising medical tourism in France to propel growth 136 TABLE 80 FRANCE: MACROECONOMIC INDICATORS 137 TABLE 81 FRANCE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 137 TABLE 82 FRANCE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137 TABLE 83 FRANCE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 138 TABLE 84 FRANCE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 138 TABLE 85 FRANCE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 138 TABLE 86 FRANCE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 139 11.3.4 UK 139 11.3.4.1 Growing adoption of optical imaging techniques and in vivo research applications to drive growth 139 TABLE 87 UK: MACROECONOMIC INDICATORS 140 TABLE 88 UK: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 140 TABLE 89 UK: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140 TABLE 90 UK: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 141 TABLE 91 UK: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 141 TABLE 92 UK: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 141 TABLE 93 UK: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 142 11.3.5 ITALY 142 11.3.5.1 Presence of major pharmaceutical & research institutes to drive market 142 TABLE 94 ITALY: MACROECONOMIC INDICATORS 143 TABLE 95 ITALY: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 143 TABLE 96 ITALY: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143 TABLE 97 ITALY: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 144 TABLE 98 ITALY: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 144 TABLE 99 ITALY: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 144 TABLE 100 ITALY: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 145 11.3.6 SPAIN 145 11.3.6.1 Increasing development in biomedical sciences to drive growth 145 TABLE 101 SPAIN: MACROECONOMIC INDICATORS 146 TABLE 102 SPAIN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 146 TABLE 103 SPAIN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146 TABLE 104 SPAIN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 147 TABLE 105 SPAIN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 147 TABLE 106 SPAIN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147 TABLE 107 SPAIN: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 148 11.3.7 REST OF EUROPE 148 TABLE 108 SHARE OF GERIATRIC POPULATION (AGED 65 YEARS AND ABOVE) IN ROE COUNTRIES 149 TABLE 109 REST OF EUROPE: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 149 TABLE 110 REST OF EUROPE: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149 TABLE 111 REST OF EUROPE: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 150 TABLE 112 REST OF EUROPE: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 150 TABLE 113 REST OF EUROPE: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150 TABLE 114 REST OF EUROPE: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 151 11.4 ASIA PACIFIC 151 11.4.1 ASIA PACIFIC: RECESSION IMPACT 152 FIGURE 32 ASIA PACIFIC: OPTICAL IMAGING MARKET SNAPSHOT 152 TABLE 115 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153 TABLE 116 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 153 TABLE 117 ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153 TABLE 118 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 154 TABLE 119 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 154 TABLE 120 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154 TABLE 121 ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 155 11.4.2 JAPAN 155 11.4.2.1 Established pharmaceutical & biotechnology research base to propel market 155 TABLE 122 JAPAN: MACROECONOMIC INDICATORS 156 TABLE 123 JAPAN: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 156 TABLE 124 JAPAN: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156 TABLE 125 JAPAN: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 157 TABLE 126 JAPAN: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 157 TABLE 127 JAPAN: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 157 TABLE 128 JAPAN: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 158 11.4.3 CHINA 158 11.4.3.1 Presence of large population base and favorable initiatives undertaken by authorities to aid growth 158 TABLE 129 CHINA: MACROECONOMIC INDICATORS 159 TABLE 130 CHINA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 159 TABLE 131 CHINA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159 TABLE 132 CHINA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 160 TABLE 133 CHINA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 160 TABLE 134 CHINA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160 TABLE 135 CHINA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 161 11.4.4 INDIA 161 11.4.4.1 Rising adoption of advanced diagnostic imaging technologies by healthcare providers to boost market 161 TABLE 136 INDIA: MACROECONOMIC INDICATORS 162 TABLE 137 INDIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 162 TABLE 138 INDIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162 TABLE 139 INDIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 163 TABLE 140 INDIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 163 TABLE 141 INDIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 163 TABLE 142 INDIA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 164 11.4.5 AUSTRALIA 164 11.4.5.1 Growing awareness of healthcare services and rising healthcare expenditure to support market 164 TABLE 143 AUSTRALIA: MACROECONOMIC INDICATORS 164 TABLE 144 AUSTRALIA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 165 TABLE 145 AUSTRALIA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165 TABLE 146 AUSTRALIA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 165 TABLE 147 AUSTRALIA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 166 TABLE 148 AUSTRALIA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 166 TABLE 149 AUSTRALIA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 166 11.4.6 SOUTH KOREA 167 11.4.6.1 Growing expenditure on improved healthcare services and rising geriatric population to propel growth 167 TABLE 150 SOUTH KOREA: MACROECONOMIC INDICATORS 167 TABLE 151 SOUTH KOREA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 167 TABLE 152 SOUTH KOREA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168 TABLE 153 SOUTH KOREA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 168 TABLE 154 SOUTH KOREA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 168 TABLE 155 OUTH KOREA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 169 TABLE 156 SOUTH KOREA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 169 11.4.7 REST OF ASIA PACIFIC 169 TABLE 157 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170 TABLE 158 REST OF ASIA PACIFIC: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170 TABLE 159 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 170 TABLE 160 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 171 TABLE 161 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 171 TABLE 162 REST OF ASIA PACIFIC: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 171 11.5 LATIN AMERICA 172 11.5.1 LATIN AMERICA: RECESSION IMPACT 172 TABLE 163 LATIN AMERICA: OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 172 TABLE 164 LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 173 TABLE 165 LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 173 TABLE 166 LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 173 TABLE 167 LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 174 TABLE 168 LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 174 TABLE 169 LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 174 11.5.2 BRAZIL 175 11.5.2.1 Improved GDP expenditure on healthcare 175 TABLE 170 BRAZIL: MACROECONOMIC INDICATORS 175 TABLE 171 BRAZIL: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175 TABLE 172 BRAZIL: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176 TABLE 173 BRAZIL: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 176 TABLE 174 BRAZIL: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 176 TABLE 175 BRAZIL: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 177 TABLE 176 BRAZIL: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 177 11.5.3 REST OF LATIN AMERICA 177 TABLE 177 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 178 TABLE 178 REST OF LATIN AMERICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 178 TABLE 179 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 178 TABLE 180 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 179 TABLE 181 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 179 TABLE 182 REST OF LATIN AMERICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 179 11.6 MIDDLE EAST & AFRICA 180 11.6.1 DEVELOPING HEALTHCARE INFRASTRUCTURE TO PROPEL MARKET GROWTH 180 11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 180 TABLE 183 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 181 TABLE 184 MIDDLE EAST & AFRICA: IMAGING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181 TABLE 185 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 181 TABLE 186 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2027 (USD MILLION) 182 TABLE 187 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 182 TABLE 188 MIDDLE EAST & AFRICA: OPTICAL IMAGING MARKET, BY END USER, 2020–2027 (USD MILLION) 182 12 COMPETITIVE LANDSCAPE 183 12.1 INTRODUCTION 183 FIGURE 33 KEY MARKET DEVELOPMENTS (JANUARY 2020 TO JANUARY 2023) 184 12.2 REVENUE SHARE ANALYSIS 185 FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET 185 12.3 MARKET SHARE ANALYSIS 186 FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPTICAL IMAGING MARKET, 2021 186 12.4 COMPANY EVALUATION QUADRANT 187 12.4.1 STARS 188 12.4.2 EMERGING LEADERS 188 12.4.3 PERVASIVE PLAYERS 188 12.4.4 PARTICIPANTS 188 FIGURE 36 OPTICAL IMAGING MARKET: GLOBAL COMPANY EVALUATION QUADRANT 189 12.5 START-UP/SME EVALUATION QUADRANT 190 12.5.1 PROGRESSIVE COMPANIES 190 12.5.2 STARTING BLOCKS 190 12.5.3 RESPONSIVE COMPANIES 190 12.5.4 DYNAMIC COMPANIES 190 FIGURE 37 OPTICAL IMAGING MARKET: GLOBAL START-UP/SME MATRIX 191 12.6 COMPETITIVE BENCHMARKING 192 12.6.1 COMPANY FOOTPRINT FOR KEY PLAYERS 192 12.6.2 PRODUCT FOOTPRINT 193 12.6.3 TECHNIQUE FOOTPRINT 194 12.6.4 THERAPEUTIC AREA FOOTPRINT 195 12.6.5 REGIONAL FOOTPRINT 196 12.7 GEOGRAPHIC FOOTPRINT OF KEY PLAYERS 197 FIGURE 38 GEOGRAPHIC REVENUE MIX: KEY PLAYERS 197 12.8 COMPETITIVE SITUATION AND TRENDS 197 12.8.1 PRODUCT LAUNCHES & APPROVALS 198 TABLE 189 OPTICAL IMAGING MARKET: PRODUCT LAUNCHES (JANUARY 2019 TO JANUARY 2023) 198 12.8.2 DEALS 198 TABLE 190 OPTICAL IMAGING MARKET: DEALS(JANUARY 2019 TO JANUARY 2023) 198 12.8.3 OTHER DEVELOPMENTS 199 TABLE 191 OPTICAL IMAGING MARKET: OTHER DEVELOPMENTS (JANUARY 2019 TO JANUARY 2023) 199 13 COMPANY PROFILES 200 13.1 KEY PLAYERS 200 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 13.1.1 CARL ZEISS MEDITEC AG 200 TABLE 192 CARL ZEISS MEDITEC AG: BUSINESS OVERVIEW 200 FIGURE 39 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021) 201 13.1.2 TOPCON CORPORATION 204 TABLE 193 TOPCON CORPORATION: BUSINESS OVERVIEW 204 FIGURE 40 TOPCON CORPORATION: COMPANY SNAPSHOT (2021) 205 13.1.3 CANON INC. 207 TABLE 194 CANON INC.: BUSINESS OVERVIEW 207 FIGURE 41 CANON INC.: COMPANY SNAPSHOT (2021) 208 13.1.4 ABBOTT LABORATORIES INC. 211 TABLE 195 ABBOTT LABORATORIES: BUSINESS OVERVIEW 211 FIGURE 42 ABBOTT LABORATORIES INC.: COMPANY SNAPSHOT (2021) 212 13.1.5 KONINKLIJKE PHILIPS N.V. 215 TABLE 196 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 215 FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021) 216 13.1.6 PERKINELMER, INC. 218 TABLE 197 PERKINELMER, INC.: BUSINESS OVERVIEW 218 FIGURE 44 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 219 13.1.7 LEICA MICROSYSTEMS (DANAHER CORPORATION) 220 TABLE 198 LEICA MICROSYSTEMS (DANAHER CORPORATION): BUSINESS OVERVIEW 220 FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 221 13.1.8 AGFA-GEVAERT N.V. 223 TABLE 199 AGFA-GEVAERT N.V.: BUSINESS OVERVIEW 223 FIGURE 46 AGFA-GEVAERT N.V.: COMPANY SNAPSHOT (2021) 224 13.1.9 HAMAMATSU PHOTONICS K.K. 225 TABLE 200 HAMAMATSU PHOTONICS K.K.: BUSINESS OVERVIEW 225 FIGURE 47 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2021) 225 13.2 OTHER PLAYERS 227 13.2.1 HEIDELBERG ENGINEERING, INC. 227 TABLE 201 HEIDELBERG ENGINEERING, INC.: BUSINESS OVERVIEW 227 13.2.2 HEADWALL PHOTONICS, INC. 229 TABLE 202 HEADWALL PHOTONICS, INC.: BUSINESS OVERVIEW 229 13.2.3 VISIONIX (FORMERLY LUNEAU TECHNOLOGY USA & OPTOVUE INC.) 231 TABLE 203 VISIONIX: BUSINESS OVERVIEW 231 13.2.4 OPTICAL IMAGING LTD. 233 TABLE 204 OPTICAL IMAGING LTD.: BUSINESS OVERVIEW 233 13.2.5 OPTOS 234 TABLE 205 OPTOS: BUSINESS OVERVIEW 234 13.2.6 WASATCH PHOTONICS 235 TABLE 206 WASATCH PHOTONICS: BUSINESS OVERVIEW 235 13.2.7 ARCSCAN INC. 236 TABLE 207 ARCSCAN INC.: BUSINESS OVERVIEW 236 13.2.8 DERMALUMICS 237 TABLE 208 DERMALUMICS: BUSINESS OVERVIEW 237 13.2.9 CYLITE PTY LTD. 238 TABLE 209 CYLITE PTY LTD.: BUSINESS OVERVIEW 238 13.2.10 MOPTIM 239 TABLE 210 MOPTIM: BUSINESS OVERVIEW 239 13.2.11 MICHELSON DIAGNOSTICS LTD. 240 TABLE 211 MICHELSON DIAGNOSTICS LTD.: BUSINESS OVERVIEW 240 13.2.12 THORLABS 241 TABLE 212 THORLABS: BUSINESS OVERVIEW 241 13.2.13 ITHERAMEDICAL 242 TABLE 213 ITHERAMEDICAL: BUSINESS OVERVIEW 242 13.2.14 KIBERO 244 TABLE 214 KIBERO: BUSINESS OVERVIEW 244 13.2.15 SENO MEDICAL 246 TABLE 215 SENO MEDICAL: BUSINESS OVERVIEW 246 13.2.16 ASPECTUS IMAGING 248 TABLE 216 ASPECTUS IMAGING: BUSINESS OVERVIEW 248 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 14 APPENDIX 249 14.1 INSIGHTS FROM INDUSTRY EXPERTS 249 14.2 DISCUSSION GUIDE 250 14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 255 14.4 CUSTOMIZATION OPTIONS 257 14.5 RELATED REPORTS 257 14.6 AUTHOR DETAILS 258
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
MarketsandMarkets社のMedical Devices分野での最新刊レポート
本レポートと同じKEY WORD(dermatology)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |